慢性複雑性尿路感染症に対するT-1220 (Piperacillin) の臨床効果

書誌事項

タイトル別名
  • CLINICAL EVALUATION OF T-1220 (PIPERACILLIN) IN CHRONIC COMPLICATED URINARY TRACT INFECTION
  • マンセイ フクザツセイ ニョウロ カンセンショウ ニ タイスル T 1220

この論文をさがす

抄録

T-1220 was administered to 27 patients with chronic urinary tract infections.<BR>Twenty cases were available for analysis of clinical evaluation of T-1220. Excellent results were observed in 7 cases, good in 8, and poor in 5. Effective rate was 75%.<BR>Urinary organisms isolated from the patients were 9 Serratia, 5 Pseudomonas, 3 Citrobacter, 2 E. coil and 1 Enterobacter. Clinical effects were observed in all cases of Pseudomonas, E. colt and Enterobacter, 6 of Serratia and 1 of Citrobacter.<BR>As side effect with T-1220, drug eruption was noticed in 1 of 27 cases.

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ